Stryker Misses Q1, Cyberattack Impacts Performance

Strykers Q1 earnings missed Wall Streets expectations, with softer demand for implants and orthopedic surgery gear. The companys top earner, medical surgery and neurotechnology, grew by 5% but fell short of estimates. Orthopedics performed better, increasing by 6.3%. Shares dropped 1.8% in after-hours trading following a cyberattack by an Iranian-linked group, which disrupted systems and delayed surgeries. Despite these challenges, Stryker maintains a steady full-year outlook, competing with Zimmer Biomet and Johnson & Johnson in orthopedics. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/baf96cdb81500483